TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 35.80
0.00 (0.00%)
Sep 15, 2026, 1:27 PM CST
TCI GENE Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 947 | 939 | 1,434 | 2,225 | 3,109 | - | |
Market Cap Growth | -13.73% | -34.50% | -35.55% | -28.42% | - | - |
Enterprise Value | 116 | 88 | 472 | 1,279 | 2,223 | - |
Last Close Price | 35.80 | 35.50 | 51.80 | 79.30 | 108.23 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.86 | 23.15 | 25.47 | 190.63 | 43.09 | - |
PS Ratio | 3.77 | 3.43 | 4.13 | 6.67 | 7.33 | - |
PB Ratio | 1.01 | 1.03 | 1.44 | 2.20 | 3.05 | - |
P/TBV Ratio | 1.04 | 1.06 | 1.48 | 2.27 | 3.11 | - |
P/FCF Ratio | 8.86 | 6.22 | 26.36 | 143.91 | 32.25 | - |
P/OCF Ratio | 8.84 | 6.21 | 25.17 | 124.67 | 28.17 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.46 | 0.32 | 1.36 | 3.83 | 5.24 | - |
EV/EBITDA Ratio | 3.72 | 3.32 | 7.90 | 84.68 | 19.84 | - |
EV/EBIT Ratio | 5.58 | 4.22 | 9.00 | 215.77 | 24.55 | - |
EV/FCF Ratio | 1.08 | 0.59 | 8.68 | 82.75 | 23.06 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.01 | - | 0.01 | 0.00 | 0.02 |
Debt / EBITDA Ratio | 0.08 | 0.19 | - | 0.30 | 0.02 | 0.05 |
Debt / FCF Ratio | 0.03 | 0.04 | - | 0.40 | 0.02 | 0.07 |
Net Debt / Equity Ratio | -0.91 | -0.90 | -0.84 | -0.88 | -0.91 | -0.83 |
Net Debt / EBITDA Ratio | -25.31 | -30.92 | -13.96 | -58.96 | -8.33 | -2.21 |
Net Debt / FCF Ratio | -7.98 | -5.45 | -15.34 | -57.62 | -9.68 | -3.35 |
Asset Turnover | 0.23 | 0.26 | 0.31 | 0.29 | 0.49 | 0.99 |
Inventory Turnover | 4.19 | 3.87 | 2.82 | 2.77 | 4.02 | 6.03 |
Quick Ratio | 8.17 | 8.92 | 9.28 | 6.43 | 7.05 | 2.64 |
Current Ratio | 8.52 | 9.27 | 9.82 | 6.87 | 7.52 | 2.87 |
Return on Equity (ROE) | 5.55% | 4.09% | 5.63% | 1.67% | 10.54% | 30.39% |
Return on Assets (ROA) | 1.69% | 1.24% | 2.90% | 0.32% | 6.57% | 16.17% |
Return on Invested Capital (ROIC) | 35.10% | 16.54% | 31.06% | 5.75% | 96.49% | 169.04% |
Return on Capital Employed (ROCE) | 3.10% | 2.30% | 5.30% | 0.60% | 8.90% | 29.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.34% | 4.32% | 3.93% | 0.53% | 2.32% | - |
FCF Yield | 11.29% | 16.07% | 3.79% | 0.69% | 3.10% | - |
Dividend Yield | 5.63% | - | 3.86% | 1.26% | 1.85% | - |
Payout Ratio | 104.54% | 130.45% | 46.98% | 453.33% | 74.36% | - |
Buyback Yield / Dilution | -0.30% | -0.30% | -0.18% | -7.71% | -24.22% | -5.74% |
Total Shareholder Return | 5.33% | -0.30% | 3.68% | -6.45% | -22.37% | -5.74% |